AI Reputation Analysis and Signal Evaluation – Amgen (AVSOLA)

B
Reputation Level
Medical Devices, Pharma & Biotech
59.3 Avg Reputation

Based on 784 businesses audited.

Brand AI Reputation

Medical Devices, Pharma & Biotech Reputation: Amgen (AVSOLA) (avsola.com)

https://avsola.com 📍 Industry: Medical Devices, Pharma & Biotech
60 Reputation / 100

AVSOLA presents a bifurcated profile: the medical content is high-substance and low-BS, while the corporate branding is high-fluff. The score of 40 reflects a site that is legally required to be honest about its product but chooses to be generically vague about its brand authority.

Info Density Power-words vs. Substance ratio.
19 63% Reputation
View evidence →
Semantic Coherence Homepage promise vs. Sub-page reality.
19 95% Reputation
View evidence →
Trust & Proof Verifiable evidence vs. Trust Theatre.
7 35% Reputation
View evidence →
Commodity Fingerprint Detection of industry clichés/templates.
10 67% Reputation
View evidence →
Identity & Authority Expert verifiability & Schema depth.
5 33% Reputation
View evidence →

Medical Devices, Pharma & Biotech Reputation: Amgen (AVSOLA) (avsola.com)

Reputation: 60 / 100

The content perfectly aligns with the Medical Pharma & Biotech category. It focuses on AVSOLA (infliximab-axxq), a biosimilar drug, and provides the heavy regulatory documentation required for this industry, such as Boxed Warnings and Important Safety Information.

“The score was primarily driven by the trust_and_proof pillar (13/20) due to the presence of unverified reviews and the identity_and_authority pillar (10/15) due to the complete absence of schema data. The high substance of the clinical information kept the information_density score relatively low for a corporate site.”

Verified Analysis Date: May 29, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result